Atlas Trials

Study to Evaluate the Potential of Air Structuring Protein to Elicit Allergic Reactions in Mold Sensitized People

Clinical trial NCT01494194 · COMPLETED

Trial details

NCT number
NCT01494194
Sponsor
Unilever SEAC
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Allergy to Mold
Start date
2011-12-01
Primary completion
2012-07-01
Enrollment
252

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.